INVENTING THE FUTURE OF MEDICINE
Alumni – UW Bioengineering – Archive
A-Alpha Bio, a startup co-founded and led by UW Bioengineering alumni David Younger (Ph.D. ’17), and Randolph Lopez (Ph.D. ’18, received a $620,472 grant from the National Science Foundation to continue developing their AlphaSeq platform for the discovery of molecular glues.
UW Bioengineering alumna Jane Grande-Allen (Ph.D. ’98) has received the UW College of Engineering’s 2020 Diamond Award for Distinguished Achievement in Academia.
Nanodropper, a company co-founded by UW Bioengineering alumna Mackenzie Andrews, MS ’19, has completed this year’s Jones + Foster Accelerator program and received $25,000 in seed funding.
Nanodropper, a company co-founded by University of Washington Bioengineering alumna Mackenzie Andrews, MS ’19, has completed this year’s Jones + Foster Accelerator program and received $25,000 in seed funding.
UW Bioengineering alumnus Wayne Gombotz (M.S. ’85, Ph.D. ’88) has received the College of Engineering’s 2019 Diamond Award for Distinguished Achievement in Industry. Dr. Gombotz's work has provided the basis of many drug delivery strategies in use and development today; multiple successful therapeutic products and processes to treat cancer, infectious diseases and autoimmune diseases; and it spurred the development of the biotechnology industry in Seattle.
UW Bioengineering alumni Anna Blakney, Abbi Helfer, Emily Krogstad and Lael Wentland received Whitaker International Fellows and Scholars Program awards in 2016 to pursue independent research projects abroad. They talk about their experiences researching and living in England, Australia, South Africa and Vietnam.
Amanda Woodcock (B.S., '15) discusses discovering the field of product development as a senior at UW and how she decided to pursue the field as a career. "I love being in the trenches, brainstorming and coming up with solutions to the most difficult problems,"
UW Bioengineering Ph.D. program alumnus Alex Jiao’s startup Silene Biotech wants to help you to grow a new heart or liver – in case those organs fail later in life.
In this professional master's degree program, students gain cutting-edge knowledge in basic bioscience, drug discovery and pharmaceutics, and learn how to apply their expertise to market-based demands of pharmaceutical industry.
A drive to engineer solutions to global health problems compelled recent Yager lab Ph.D. graduate Joshua Buser to pursue bioengineering. He aims to bring diagnostic testing to low-resource settings – and increase access to affordable health care closer to home.
